Privia Health Group (NASDAQ:PRVA) Research Coverage Started at Needham & Company LLC

Needham & Company LLC assumed coverage on shares of Privia Health Group (NASDAQ:PRVA) in a research report report published on Friday, MarketBeat Ratings reports. The firm issued a buy rating and a $25.00 price target on the stock.

Several other research analysts have also recently weighed in on the stock. Stephens restated an “overweight” rating and set a $26.00 price target on shares of Privia Health Group in a report on Thursday, January 2nd. Truist Financial upped their target price on Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a report on Friday, November 8th. Barclays lifted their price target on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a report on Friday, November 8th. Macquarie started coverage on Privia Health Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $25.00 price objective for the company. Finally, KeyCorp assumed coverage on shares of Privia Health Group in a report on Friday, October 11th. They issued an “overweight” rating and a $23.00 price target on the stock. Two research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $24.88.

Privia Health Group Price Performance

Shares of NASDAQ PRVA opened at $20.51 on Friday. The company has a 50-day moving average price of $20.93 and a 200-day moving average price of $19.47. The stock has a market capitalization of $2.46 billion, a P/E ratio of 205.12, a P/E/G ratio of 5.45 and a beta of 0.85. Privia Health Group has a 1 year low of $15.92 and a 1 year high of $23.24.

Institutional Investors Weigh In On Privia Health Group

Several institutional investors have recently made changes to their positions in the company. Millennium Management LLC increased its stake in Privia Health Group by 2,994.2% in the second quarter. Millennium Management LLC now owns 1,138,526 shares of the company’s stock worth $19,788,000 after purchasing an additional 1,101,730 shares during the period. Eventide Asset Management LLC lifted its holdings in Privia Health Group by 979.2% during the 3rd quarter. Eventide Asset Management LLC now owns 822,438 shares of the company’s stock valued at $14,977,000 after buying an additional 746,231 shares in the last quarter. Icon Wealth Advisors LLC boosted its position in Privia Health Group by 1,910.1% in the 3rd quarter. Icon Wealth Advisors LLC now owns 300,889 shares of the company’s stock valued at $5,479,000 after buying an additional 285,920 shares during the period. FMR LLC grew its stake in Privia Health Group by 1.5% in the 3rd quarter. FMR LLC now owns 18,169,043 shares of the company’s stock worth $330,858,000 after acquiring an additional 271,645 shares in the last quarter. Finally, BlackBarn Capital Partners LP increased its position in shares of Privia Health Group by 100.0% during the second quarter. BlackBarn Capital Partners LP now owns 400,000 shares of the company’s stock worth $6,952,000 after acquiring an additional 200,000 shares during the period. Institutional investors own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.